Cargando…
Choriorétinopathie séreuse centrale bilatérale post-COVID-19
Coronavirus disease (COVID-19) can result in many ocular manifestations. We report a rare case of bilateral central serous chorioretinopathy post-infection with COVID-19 in a 38-year-old woman who presented with bilateral blurred vision 1 month after infection with COVID-19. She reported fever, coug...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520853/ https://www.ncbi.nlm.nih.gov/pubmed/34756744 http://dx.doi.org/10.1016/j.jfo.2021.10.001 |
_version_ | 1784584768703168512 |
---|---|
author | Mahjoub, A. Dlensi, A. Romdhane, A. Ben Abdesslem, N. Mahjoub, A. Bachraoui, C. Mahjoub, H. Ghorbel, M. Knani, L. Krifa, F. |
author_facet | Mahjoub, A. Dlensi, A. Romdhane, A. Ben Abdesslem, N. Mahjoub, A. Bachraoui, C. Mahjoub, H. Ghorbel, M. Knani, L. Krifa, F. |
author_sort | Mahjoub, A. |
collection | PubMed |
description | Coronavirus disease (COVID-19) can result in many ocular manifestations. We report a rare case of bilateral central serous chorioretinopathy post-infection with COVID-19 in a 38-year-old woman who presented with bilateral blurred vision 1 month after infection with COVID-19. She reported fever, cough, and shortness of breath and was COVID-PCR positive. During her 10-day hospital stay, she received oxygen, antibiotics, heparin and corticosteroids intravenously and then orally. After her recovery from COVID-19, the patient developed progressive visual loss in both eyes: her corrected visual acuity was 3/10 in both eyes, the anterior segment was normal, and the vitreous was clear. Fundus examination, optical coherence tomography and fluorescein angiography showed bilateral serous retinal detachments. Her course was characterized by improvement in visual acuity and regression of the retinal detachments. Central serous chorioretinopathy can occur after COVID-19 infection due to the administration of corticosteroids; thus, ophthalmologic examination is essential to detect ocular involvement as early as possible. |
format | Online Article Text |
id | pubmed-8520853 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85208532021-10-18 Choriorétinopathie séreuse centrale bilatérale post-COVID-19 Mahjoub, A. Dlensi, A. Romdhane, A. Ben Abdesslem, N. Mahjoub, A. Bachraoui, C. Mahjoub, H. Ghorbel, M. Knani, L. Krifa, F. J Fr Ophtalmol Article Original Coronavirus disease (COVID-19) can result in many ocular manifestations. We report a rare case of bilateral central serous chorioretinopathy post-infection with COVID-19 in a 38-year-old woman who presented with bilateral blurred vision 1 month after infection with COVID-19. She reported fever, cough, and shortness of breath and was COVID-PCR positive. During her 10-day hospital stay, she received oxygen, antibiotics, heparin and corticosteroids intravenously and then orally. After her recovery from COVID-19, the patient developed progressive visual loss in both eyes: her corrected visual acuity was 3/10 in both eyes, the anterior segment was normal, and the vitreous was clear. Fundus examination, optical coherence tomography and fluorescein angiography showed bilateral serous retinal detachments. Her course was characterized by improvement in visual acuity and regression of the retinal detachments. Central serous chorioretinopathy can occur after COVID-19 infection due to the administration of corticosteroids; thus, ophthalmologic examination is essential to detect ocular involvement as early as possible. Elsevier Masson SAS. 2021-12 2021-10-18 /pmc/articles/PMC8520853/ /pubmed/34756744 http://dx.doi.org/10.1016/j.jfo.2021.10.001 Text en © 2021 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Original Mahjoub, A. Dlensi, A. Romdhane, A. Ben Abdesslem, N. Mahjoub, A. Bachraoui, C. Mahjoub, H. Ghorbel, M. Knani, L. Krifa, F. Choriorétinopathie séreuse centrale bilatérale post-COVID-19 |
title | Choriorétinopathie séreuse centrale bilatérale post-COVID-19 |
title_full | Choriorétinopathie séreuse centrale bilatérale post-COVID-19 |
title_fullStr | Choriorétinopathie séreuse centrale bilatérale post-COVID-19 |
title_full_unstemmed | Choriorétinopathie séreuse centrale bilatérale post-COVID-19 |
title_short | Choriorétinopathie séreuse centrale bilatérale post-COVID-19 |
title_sort | choriorétinopathie séreuse centrale bilatérale post-covid-19 |
topic | Article Original |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520853/ https://www.ncbi.nlm.nih.gov/pubmed/34756744 http://dx.doi.org/10.1016/j.jfo.2021.10.001 |
work_keys_str_mv | AT mahjouba chorioretinopathiesereusecentralebilateralepostcovid19 AT dlensia chorioretinopathiesereusecentralebilateralepostcovid19 AT romdhanea chorioretinopathiesereusecentralebilateralepostcovid19 AT benabdesslemn chorioretinopathiesereusecentralebilateralepostcovid19 AT mahjouba chorioretinopathiesereusecentralebilateralepostcovid19 AT bachraouic chorioretinopathiesereusecentralebilateralepostcovid19 AT mahjoubh chorioretinopathiesereusecentralebilateralepostcovid19 AT ghorbelm chorioretinopathiesereusecentralebilateralepostcovid19 AT knanil chorioretinopathiesereusecentralebilateralepostcovid19 AT krifaf chorioretinopathiesereusecentralebilateralepostcovid19 |